Revealing the dynamic landscape of drug-drug interactions through network analysis

Revealing the dynamic landscape of drug-drug interactions through network analysis

Introduction: The landscape of drug-drug interactions (DDIs) has evolved significantly over the past 60 years, necessitating a retrospective analysis to identify research trends and under-explored areas. While methodologies like bibliometric analysis provide valuable quantitative perspectives on DDI...

Full description

Bibliographic Details
Main Authors:	Eugene Jeong, Bradley Malin, Scott D. Nelson, Yu Su, Lang Li, You Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Series:	Frontiers in Pharmacology
Subjects:	pharmacokinetic drug-drug interaction pharmacodynamic drug-drug interaction network analysis natural language Processing research trend
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1211491/full

Similar Items

The interactions between COVID-19 drugs and psychotropic agents
by: C. Hiemke
Published: (2021-04-01)

Prevalence and Clinical Significance of Drug–Drug and Drug–Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece
by: Marios Spanakis, et al.
Published: (2021-02-01)

New Perspective for Drug–Drug Interaction in Perioperative Period
by: Abigail Silva, et al.
Published: (2023-07-01)

Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications
by: Lei Sun, et al.
Published: (2023-07-01)

Pharmacokinetic and pharmacodynamic drug-drug interaction of Nomilin with atorvastatin in hyperlipidemic mice
by: Yan Ding, et al.
Published: (2023-11-01)

Herb-drug interaction resources: The PHYDGI database
by: J. Perrot, et al.
Published: (2022-08-01)

Achillea millefolium: Mechanism of action, pharmacokinetic, clinical drug-drug interactions and tolerability
by: Bahareh Farasati Far, et al.
Published: (2023-12-01)

Editorial: Pharmacological interaction between drugs and medicinal plants, Volume II
by: Maria Eva González-Trujano, et al.
Published: (2024-01-01)

Assessment of Potential Drug-drug Interactions among Ischaemic Stroke Patients in a Charitable Hospital
by: Amala Johnson, et al.
Published: (2022-07-01)

Model-Informed Drug Discovery and Development Strategy for the Rapid Development of Anti-Tuberculosis Drug Combinations
by: Rob C. van Wijk, et al.
Published: (2020-03-01)

Personalized Medicine for Classical Anesthesia Drugs and Cancer Progression
by: Bárbara Costa, et al.
Published: (2022-11-01)

Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions
by: Kolli P, et al.
Published: (2023-12-01)

Direct Acting Antiviral Drugs: Pharmacokinetics and Drug-Drug Interactions
by: Marina Barakat, et al.
Published: (2022-12-01)

Drug–Drug Interactions between Tamsulosin and Mirabegron in Healthy Individuals Do Not Affect Pharmacokinetics and Hemodynamic Parameters Significantly
by: Wonsuk Shin, et al.
Published: (2023-10-01)

Pharmacokinetic and pharmacodynamic herb-drug interactions—part I. Herbal medicines of the central nervous system
by: Szilvia Czigle, et al.
Published: (2023-11-01)

Editorial: Drug-drug interactions in pharmacology
by: Simona Pichini, et al.
Published: (2023-02-01)

The Impact of Diet and Exercise on Drug Responses
by: Ellen Niederberger, et al.
Published: (2021-07-01)

Comorbid epilepsy and depression—pharmacokinetic and pharmacodynamic drug interactions
by: Barbara Miziak, et al.
Published: (2022-10-01)

Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects
by: Rhee SJ, et al.
Published: (2016-08-01)

Differential Preincubation Effects of Nicardipine on OATP1B1- and OATP1B3-Mediated Transport in the Presence and Absence of Protein: Implications in Assessing OATP1B1- and OATP1B3-Mediated Drug–Drug Interactions
by: Ruhul Kayesh, et al.
Published: (2023-03-01)

Advances in Pharmacokinetic Mechanisms of Transporter-Mediated Herb-Drug Interactions
by: Jie Li, et al.
Published: (2022-09-01)

Prediction of the Drug–Drug Interaction Potential between Tegoprazan and Amoxicillin/Clarithromycin Using the Physiologically Based Pharmacokinetic and Pharmacodynamic Model
by: Zhuodu Wei, et al.
Published: (2023-02-01)

Drug–Drug–Gene Interactions in Cardiovascular Medicine
by: Asiimwe IG, et al.
Published: (2022-11-01)

Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase
by: Silvia Fernandez, et al.
Published: (2021-03-01)

The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review
by: Dario Cattaneo, et al.
Published: (2022-10-01)

Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers
by: Hae Won Lee, et al.
Published: (2020-09-01)

Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice
by: Nicola Ferri, et al.
Published: (2022-05-01)

The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug–Drug Interactions: Drug–Gene, Drug–Gene–Gene and Drug–Drug–Gene Interactions
by: Martina Hahn, et al.
Published: (2021-05-01)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
by: Lien Thi Ngo, et al.
Published: (2020-10-01)

Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative
by: Muh. Akbar Bahar, et al.
Published: (2020-11-01)

Potential drug-drug interactions in outpatients with depression of a psychiatry department
by: Yang Chen, et al.
Published: (2023-02-01)

An LC-MS/MS method for the simultaneous determination of 18 antibacterial drugs in human plasma and its application in therapeutic drug monitoring
by: Wei Lu, et al.
Published: (2022-11-01)

Drug Design: Where We Are and Future Prospects
by: Giuseppe Zagotto, et al.
Published: (2021-11-01)

A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine
by: Tobias Kanacher, et al.
Published: (2020-12-01)

Deep learning-enabled natural language processing to identify directional pharmacokinetic drug–drug interactions
by: Joel Zirkle, et al.
Published: (2023-11-01)

Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance
by: Laura Rombolà, et al.
Published: (2020-07-01)

Prediction of Cyclosporin-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Model Characterizing Interplay of Drug Transporters and Enzymes
by: Yiting Yang, et al.
Published: (2020-09-01)

Physiological and Pharmacokinetic Alterations and Drug-Nutrient Interactions During Pregnancy
by: Gözde Ede, et al.
Published: (2017-09-01)

Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations
by: Shawn Flanagan, et al.
Published: (2023-06-01)

Editorial: Pharmacokinetics of herbal medicines and herb-drug interactions
by: Wei-Wei Jia, et al.
Published: (2022-12-01)